InvestorsHub Logo
Followers 0
Posts 107
Boards Moderated 0
Alias Born 03/07/2017

Re: None

Friday, 07/14/2017 1:19:35 PM

Friday, July 14, 2017 1:19:35 PM

Post# of 1399
($HADV) Sales of Legal Cannabis Products are Expected to Accelerate

According to a research report by New Frontier Data, medical cannabis sales are forecast to grow to $5.3 billion in 2017 and accounting for 67% of total cannabis sales. By 2025, medical sales in currently legal states are forecast to grow to $13.2 billion, at which point medical sales will account for 55% of all sales. Comparatively, adult-use sales in 2017 are forecast to reach $2.6 billion and rising to $10.9 billion by 2025. The report also indicates that in 2016 alone, adult-use consumers shopped once every 14 days and spent $49 per transaction. Medical consumers, by contrast, shop once every 10 days and outspend the adult-use customer by more than three-to-one or spending $136 per transaction. Invictus MD Strategies Corp. (OTC: IVITF), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), GW Pharmaceuticals plc (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA), Insys Therapeutics Inc. (NASDAQ: INSY).

Source: http://www.prnewswire.com/news-releases/sales-of-legal-cannabis-products-are-expected-to-accelerate-634476303.html